Related Experiment Video
Updated: Jun 23, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Family physicians and dementia in Canada: Part 1. Clinical practice guidelines: awareness, attitudes, and opinions
Nicholas J G Pimlott1, Malini Persaud, Neil Drummond
1Women's College Hospital, 60 Grosvenor St, Toronto, ON M5S 1B6, Canada. nick.pimlott@utoronto.ca
Objective:
To assess Canadian family physicians' awareness of, attitudes toward, and use of the 1999 Canadian Consensus Conference on Dementia (CCCD) clinical practice guidelines (CPGs); to explore the barriers and enablers to implementing dementia CPGs in clinical practice; and to identify more effective strategies for future dementia guideline development and dissemination.
Design:
Qualitative study using focus groups.
Setting:
Academic family practice clinics in Calgary, Alta, Ottawa, Ont, and Toronto, Ont.
Participants:
Eighteen family physicians.
Methods:
Using a semistructured interview guide, we conducted 4 qualitative focus groups of 4 to 6 family physicians whose practices we had audited in a previous study. Transcripts were coded using an inductive data analytic strategy, and categories and themes were identified and described using the principles of thematic analysis.
Main Findings:
Four major themes emerged from the focus group discussions. Family physicians 1) were minimally aware of the existence and the detailed contents of the CCCD guidelines; 2) had strong views about the purposes of guidelines in general; 3) expressed strong concerns about the role of the pharmaceutical industry in the development of such guidelines; and 4) had many ideas to improve future dementia guidelines and CPGs in general.
Conclusion:
Family physicians were minimally aware of the 1999 CCCD CPGs. They acknowledged, however, the potential of future CPGs to assist them in patient care and offered many strategies to improve the development and dissemination of future dementia guidelines. Future guidelines should more accurately reflect the day-to-day practice experiences and challenges of family physicians, and guideline developers should also be cognizant of family physicians' perceptions that pharmaceutical companies' funding of CPGs undermines the objectivity and credibility of those guidelines.
Related Concept Videos
Dementia
The progression of dementia is generally gradual.
Dementia l: Introduction
Alzheimer Disease l: Introduction
Documentation in Long-Term and Home Healthcare Setting
Long-Term Care Facilities
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Drug Dosing: Geriatric Patients
